CORRECTING and REPLACING -- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty
03 Aprile 2013 - 8:51PM
In a press release issued today by Levi & Korsinsky with the
same headline, please note that the per share amount in the third
paragraph should be $24.00, not $19.75 as originally stated. The
corrected release follows:
Levi & Korsinsky notifies investors of Obagi Medical
Products, Inc. ("Obagi" or the "Company") (Nasdaq:OMPI) of claims
of breaches of fiduciary duty and other violations of state law
against the board of directors of the Company in connection with
the sale of the Company to Valeant Pharmaceuticals International,
Inc. (NYSE:VRX). A complaint was filed in Delaware state court.
Click here to learn how to join the action:
http://zlk.9nl.com/obagi-medical-products-ompi/,
or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Obagi shareholders will
receive $24.00 for each share of Obagi common stock they own. The
claims concern whether the Obagi Board of Directors breached their
fiduciary duties to stockholders by failing to adequately shop the
Company before entering into this transaction and whether Valeant
Pharmaceuticals International, Inc. is underpaying for Obagi
shares, thus unlawfully harming Obagi stockholders.
If you own common stock in Obagi and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email
at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free:
(877) 363-5972, or
http://zlk.9nl.com/obagi-medical-products-ompi/.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, and Washington D.C. The firm has extensive
expertise in prosecuting securities litigation involving financial
fraud, representing investors throughout the nation in securities
and shareholder lawsuits. The attorneys at Levi &
Korsinsky have been appointed by numerous courts throughout the
country to serve as lead counsel on behalf of shareholders in major
securities lawsuits and have successfully recovered
multimillion-dollar damages awards on behalf of investors.
For more information, please feel free to contact any of the
attorneys listed below. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
Grafico Azioni Obagi Medical Products, Inc. (MM) (NASDAQ:OMPI)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Obagi Medical Products, Inc. (MM) (NASDAQ:OMPI)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Obagi Medical Products, Inc. (MM) (NASDAQ): 0 articoli recenti
Più Articoli Notizie